Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 53

1.

Endothelial dysfunction in patients with granulomatosis with polyangiitis: a case-control study.

Pacholczak R, Bazan-Socha S, Iwaniec T, Zaręba L, Kielczewski S, Walocha JA, Musiał J, Dropiński J.

Rheumatol Int. 2018 Aug;38(8):1521-1530. doi: 10.1007/s00296-018-4061-x. Epub 2018 May 30.

PMID:
29850964
2.

Discovery of MK-8722: A Systemic, Direct Pan-Activator of AMP-Activated Protein Kinase.

Feng D, Biftu T, Romero FA, Kekec A, Dropinski J, Kassick A, Xu S, Kurtz MM, Gollapudi A, Shao Q, Yang X, Lu K, Zhou G, Kemp D, Myers RW, Guan HP, Trujillo ME, Li C, Weber A, Sebhat IK.

ACS Med Chem Lett. 2017 Dec 1;9(1):39-44. doi: 10.1021/acsmedchemlett.7b00417. eCollection 2018 Jan 11.

PMID:
29348809
3.

Oxyfunctionalization of the Remote C-H Bonds of Aliphatic Amines by Decatungstate Photocatalysis.

Schultz DM, Lévesque F, DiRocco DA, Reibarkh M, Ji Y, Joyce LA, Dropinski JF, Sheng H, Sherry BD, Davies IW.

Angew Chem Int Ed Engl. 2017 Nov 27;56(48):15274-15278. doi: 10.1002/anie.201707537. Epub 2017 Oct 26.

PMID:
29044797
4.

A multifunctional catalyst that stereoselectively assembles prodrugs.

DiRocco DA, Ji Y, Sherer EC, Klapars A, Reibarkh M, Dropinski J, Mathew R, Maligres P, Hyde AM, Limanto J, Brunskill A, Ruck RT, Campeau LC, Davies IW.

Science. 2017 Apr 28;356(6336):426-430. doi: 10.1126/science.aam7936.

PMID:
28450641
5.

Chemistry informer libraries: a chemoinformatics enabled approach to evaluate and advance synthetic methods.

Kutchukian PS, Dropinski JF, Dykstra KD, Li B, DiRocco DA, Streckfuss EC, Campeau LC, Cernak T, Vachal P, Davies IW, Krska SW, Dreher SD.

Chem Sci. 2016 Apr 21;7(4):2604-2613. doi: 10.1039/c5sc04751j. Epub 2016 Jan 26.

6.

Correction: The Relationship of Metabolic Syndrome with Stress, Coronary Heart Disease and Pulmonary Function - An Occupational Cohort-Based Study.

Janczura M, Bochenek G, Nowobilski R, Dropinski J, Kotula-Horowitz K, Laskowicz B, Stanisz A, Lelakowski J, Domagala T.

PLoS One. 2015 Sep 24;10(9):e0139408. doi: 10.1371/journal.pone.0139408. eCollection 2015. No abstract available.

7.

The Relationship of Metabolic Syndrome with Stress, Coronary Heart Disease and Pulmonary Function--An Occupational Cohort-Based Study.

Janczura M, Bochenek G, Nowobilski R, Dropinski J, Kotula-Horowitz K, Laskowicz B, Stanisz A, Lelakowski J, Domagala T.

PLoS One. 2015 Aug 14;10(8):e0133750. doi: 10.1371/journal.pone.0133750. eCollection 2015. Erratum in: PLoS One. 2015;10(9):e0139408.

8.

Synthesis and antibacterial activity of novel water-soluble nocathiacin analogs.

Xu L, Farthing AK, Dropinski JF, Meinke PT, McCallum C, Hickey E, Liu K.

Bioorg Med Chem Lett. 2013 Jan 1;23(1):366-9. doi: 10.1016/j.bmcl.2012.10.065. Epub 2012 Oct 23.

PMID:
23164707
9.

Nitric oxide production and endothelium-dependent vasorelaxation ameliorated by N1-methylnicotinamide in human blood vessels.

Domagala TB, Szeffler A, Dobrucki LW, Dropinski J, Polanski S, Leszczynska-Wiloch M, Kotula-Horowitz K, Wojciechowski J, Wojnowski L, Szczeklik A, Kalinowski L.

Hypertension. 2012 Apr;59(4):825-32. doi: 10.1161/HYPERTENSIONAHA.111.183210. Epub 2012 Feb 21.

10.

[Severe dilated cardiomyopathy as a complication of well controlled Churg-Strauss syndrome].

Sokołowska B, Szczeklik W, Mastalerz L, Miszalski-Jamka T, Dropiński J, Kumik J, Ziółkowska-Graca B, Pasowicz M, Musiał J.

Kardiol Pol. 2011;69(3):257-60. Polish.

11.

Impaired cardiovascular autonomic nervous system function in patients with Churg-Strauss syndrome.

Szczeklik W, Tutaj M, Sokołowska B, Mastalerz L, Miszalski-Jamka T, Dropiński J, Musiał J.

Scand J Rheumatol. 2011;40(4):304-7. doi: 10.3109/03009742.2010.549500. Epub 2011 Mar 2.

PMID:
21366384
12.

Multimodality assessment of cardiac involvement in Churg-Strauss syndrome patients in clinical remission.

Szczeklik W, Miszalski-Jamka T, Mastalerz L, Sokolowska B, Dropinski J, Banys R, Hor KN, Mazur W, Musial J.

Circ J. 2011;75(3):649-55. Epub 2010 Dec 3.

13.

Influence of leukotriene biosynthesis inhibition on heart rate in patients with atrial fibrillation.

Sokołowska B, Dropinski J, Rzeszutko M, Szczeklik W, Sanak M, Szczeklik A.

Int J Cardiol. 2010 Dec 3;145(3):625-6. doi: 10.1016/j.ijcard.2010.09.038. No abstract available.

PMID:
20937532
14.

Pharmacological inhibition of leukotriene biosynthesis: effects on the heart conductance.

Sanak M, Dropinski J, Sokolowska B, Faber J, Rzeszutko M, Szczeklik A.

J Physiol Pharmacol. 2010 Feb;61(1):53-8.

15.

Nocathiacin analogs: Synthesis and antibacterial activity of novel water-soluble amides.

Xu L, Farthing AK, Dropinski JF, Meinke PT, McCallum C, Leavitt PS, Hickey EJ, Colwell L, Barrett J, Liu K.

Bioorg Med Chem Lett. 2009 Jul 1;19(13):3531-5. doi: 10.1016/j.bmcl.2009.04.144. Epub 2009 May 5.

PMID:
19447613
16.

Clinical correlate of brain SPECT perfusion abnormalities in fibromyalgia.

Guedj E, Cammilleri S, Niboyet J, Dupont P, Vidal E, Dropinski JP, Mundler O.

J Nucl Med. 2008 Nov;49(11):1798-803. doi: 10.2967/jnumed.108.053264. Epub 2008 Oct 16.

17.

[Congestive cardiomyopathy and left intraventricular thrombus as a manifestation of Churg-Strauss syndrome].

Dropiński J, Szczeklik W, Sokołowska B, Celińska-Lowenhoff M, Milewski M, Szczeklik A.

Kardiol Pol. 2008 Jul;66(7):761-3. Polish.

PMID:
18690568
18.

[Cholestatic hepatitis as a ticlopidine-induced complication of treatment - a case report].

Kowalski R, Dropiński J, Brzostek T, Szot P, Rzeszutko M, Kasper M, Sawicka A, Szczeklik A.

Kardiol Pol. 2008 Jul;66(7):758-60. Polish.

PMID:
18690567
19.

The additive antiplatelet action of clopidogrel in patients with coronary artery disease treated with aspirin.

Dropinski J, Jakiela B, Sanak M, Wegrzyn W, Biernat M, Dziedzina S, Plutecka H, Szczeklik A.

Thromb Haemost. 2007 Jul;98(1):201-9.

PMID:
17598014
20.

[Recurrent crural phlegmonous abscesses as a sign of Münchausen syndrome in a young woman].

Dropiński J, Wegrzyn W, Szczeklik W, Szułdrzynski K, Sznajd J.

Przegl Lek. 2006;63(5):304-5. Polish.

PMID:
17036511
21.

Antithrombotic effects of aspirin based on PLA1/A2 glycoprotein IIIa polymorphism in patients with coronary artery disease.

Dropinski J, Musial J, Sanak M, Wegrzyn W, Nizankowski R, Szczeklik A.

Thromb Res. 2007;119(3):301-3. Epub 2006 May 3.

PMID:
16675000
22.

Anti-thrombotic action of clopidogrel and P1(A1/A2) polymorphism of beta3 integrin in patients with coronary artery disease not being treated with aspirin.

Dropinski J, Musial J, Jakiela B, Wegrzyn W, Sanak M, Szczeklik A.

Thromb Haemost. 2005 Dec;94(6):1300-5.

PMID:
16411409
23.

[Thrombotic thrombocytopenic purpura -- a rare complication associated with clopidogrel therapy. A case report].

Szułdrzyński K, Dropiński J, Szczeklik W.

Kardiol Pol. 2005 Oct;63(4):411-3. Polish.

PMID:
16273483
24.

Prediction of the excessive perioperative bleeding in patients undergoing coronary artery bypass grafting: role of aspirin and platelet glycoprotein IIIa polymorphism.

Morawski W, Sanak M, Cisowski M, Szczeklik M, Szczeklik W, Dropinski J, Waclawczyk T, Ulczok R, Bochenek A.

J Thorac Cardiovasc Surg. 2005 Sep;130(3):791-6.

25.

Synthesis and biological activities of novel aryl indole-2-carboxylic acid analogs as PPARgamma partial agonists.

Dropinski JF, Akiyama T, Einstein M, Habulihaz B, Doebber T, Berger JP, Meinke PT, Shi GQ.

Bioorg Med Chem Lett. 2005 Nov 15;15(22):5035-8.

PMID:
16153845
26.

Design, synthesis, and structure-activity relationship of podocarpic acid amides as liver X receptor agonists for potential treatment of atherosclerosis.

Liu W, Chen S, Dropinski J, Colwell L, Robins M, Szymonifka M, Hayes N, Sharma N, MacNaul K, Hernandez M, Burton C, Sparrow CP, Menke JG, Singh SB.

Bioorg Med Chem Lett. 2005 Oct 15;15(20):4574-8.

PMID:
16125384
27.

Early antithrombotic and anti-inflammatory effects of simvastatin versus fenofibrate in patients with hypercholesterolemia.

Undas A, Celinska-Löwenhoff M, Domagala TB, Iwaniec T, Dropinski J, Löwenhoff T, Szczeklik A.

Thromb Haemost. 2005 Jul;94(1):193-9.

PMID:
16113803
28.

Novel 2,3-dihydrobenzofuran-2-carboxylic acids: highly potent and subtype-selective PPARalpha agonists with potent hypolipidemic activity.

Shi GQ, Dropinski JF, Zhang Y, Santini C, Sahoo SP, Berger JP, Macnaul KL, Zhou G, Agrawal A, Alvaro R, Cai TQ, Hernandez M, Wright SD, Moller DE, Heck JV, Meinke PT.

J Med Chem. 2005 Aug 25;48(17):5589-99.

PMID:
16107159
29.

Design and synthesis of alpha-aryloxyphenylacetic acid derivatives: a novel class of PPARalpha/gamma dual agonists with potent antihyperglycemic and lipid modulating activity.

Shi GQ, Dropinski JF, McKeever BM, Xu S, Becker JW, Berger JP, MacNaul KL, Elbrecht A, Zhou G, Doebber TW, Wang P, Chao YS, Forrest M, Heck JV, Moller DE, Jones AB.

J Med Chem. 2005 Jun 30;48(13):4457-68.

PMID:
15974597
30.

Discovery and development of dimeric podocarpic acid leads as potent agonists of liver X receptor with HDL cholesterol raising activity in mice and hamsters.

Singh SB, Ondeyka JG, Liu W, Chen S, Chen TS, Li X, Bouffard A, Dropinski J, Jones AB, McCormick S, Hayes N, Wang J, Sharma N, Macnaul K, Hernandez M, Chao YS, Baffic J, Lam MH, Burton C, Sparrow CP, Menke JG.

Bioorg Med Chem Lett. 2005 Jun 2;15(11):2824-8.

PMID:
15911262
31.

Eosinophilic fasciitis successfully treated with cyclosporine.

Bukiej A, Dropiński J, Dyduch G, Szczeklik A.

Clin Rheumatol. 2005 Nov;24(6):634-6. Epub 2005 Apr 29.

PMID:
15864687
32.

[Hereditary hemochromatosis: molecular diagnosis and effect of treatment].

Szczeklik W, Dropiński J, Dziedzina S, Szułdrzyński K, Biesiada G, Mach T, Sanak M.

Pol Arch Med Wewn. 2004 May;111(5):593-6. Polish.

PMID:
15508811
33.

[Myocardial infraction as the first manifestation of systemic lupus erythematosus in a 22-year-old man].

Bukiej A, Dropiński J, Ryś D, Musiał J.

Pol Arch Med Wewn. 2004 Feb;111(2):213-6. Polish.

PMID:
15230234
34.

[Myocardial infarction as an initial symptom of antiphospholipid syndrome, factor V Leiden mutation, and hyperhomocysteinemia].

Dropiński J, Wegrzyn W, Szczeklik W, Krzanowski M.

Pol Arch Med Wewn. 2004 Jan;111(1):63-7. Polish.

PMID:
15088423
35.
36.

Aspirin and thrombinogenesis.

Szczeklik A, Musiał J, Undas A, Sanak M, Dropiński J, Tuleja E, Wegrzyn W.

Thromb Res. 2003 Jun 15;110(5-6):345-7. Review. No abstract available.

PMID:
14592560
37.

[Cardiac involvement in systemic autoimmune disease].

Dropiński J, Szczeklik W, Rubiś P.

Pol Arch Med Wewn. 2003 Apr;109(4):375-81. Polish.

PMID:
12931489
38.

Anti-phospholipid antibodies and carotid-artery intima-media thickness in young survivors of myocardial infarction.

Dropiński J, Szczeklik W, Rubiś P, Sydor WJ.

Med Sci Monit. 2003 Apr;9(4):BR105-9.

PMID:
12709660
39.

Mutation A1298C of methylenetetrahydrofolate reductase: risk for early coronary disease not associated with hyperhomocysteinemia.

Szczeklik A, Sanak M, Jankowski M, Dropiński J, Czachór R, Musiał J, Axenti I, Twardowska M, Brzostek T, Tendera M.

Am J Med Genet. 2001 Jun 1;101(1):36-9.

PMID:
11343335
40.

[Fabry's disease--late diagnosis in men with chronic nephropathy and skin changes].

Wegrzyn W, Undas A, Motyl R, Urbanik A, Dropiński J, Ryś D, Musiał J.

Pol Arch Med Wewn. 1999 May;101(5):419-23. Polish.

PMID:
10740422
41.

Efficacy of MK-991 (L-743,872), a semisynthetic pneumocandin, in murine models of Pneumocystis carinii.

Powles MA, Liberator P, Anderson J, Karkhanis Y, Dropinski JF, Bouffard FA, Balkovec JM, Fujioka H, Aikawa M, McFadden D, Schmatz D.

Antimicrob Agents Chemother. 1998 Aug;42(8):1985-9.

42.

Preliminary animal pharmacokinetics of the parenteral antifungal agent MK-0991 (L-743,872).

Hajdu R, Thompson R, Sundelof JG, Pelak BA, Bouffard FA, Dropinski JF, Kropp H.

Antimicrob Agents Chemother. 1997 Nov;41(11):2339-44.

43.

Evaluation of the echinocandin antifungal MK-0991 (L-743,872): efficacies in mouse models of disseminated aspergillosis, candidiasis, and cryptococcosis.

Abruzzo GK, Flattery AM, Gill CJ, Kong L, Smith JG, Pikounis VB, Balkovec JM, Bouffard AF, Dropinski JF, Rosen H, Kropp H, Bartizal K.

Antimicrob Agents Chemother. 1997 Nov;41(11):2333-8.

44.

In vitro preclinical evaluation studies with the echinocandin antifungal MK-0991 (L-743,872).

Bartizal K, Gill CJ, Abruzzo GK, Flattery AM, Kong L, Scott PM, Smith JG, Leighton CE, Bouffard A, Dropinski JF, Balkovec J.

Antimicrob Agents Chemother. 1997 Nov;41(11):2326-32.

45.

Aerosol and parenteral pneumocandins are effective in a rat model of pulmonary aspergillosis.

Kurtz MB, Bernard EM, Edwards FF, Marrinan JA, Dropinski J, Douglas CM, Armstrong D.

Antimicrob Agents Chemother. 1995 Aug;39(8):1784-9.

46.

New semisynthetic pneumocandins with improved efficacies against Pneumocystis carinii in the rat.

Schmatz DM, Powles MA, McFadden D, Nollstadt K, Bouffard FA, Dropinski JF, Liberator P, Andersen J.

Antimicrob Agents Chemother. 1995 Jun;39(6):1320-3.

47.

Thrombinogenesis and its pharmacological modulation in atherosclerosis.

Szczeklik A, Musiał J, Dropiński J, Krzanowski M, Królikowski W, Undas A, Swadźba J, Duplaga M, Bodzoń W.

J Physiol Pharmacol. 1994 Mar;45(1):3-11. Review.

PMID:
8043909
48.

Synthesis and antifungal activity of novel cationic pneumocandin B(o) derivatives.

Bouffard FA, Zambias RA, Dropinski JF, Balkovec JM, Hammond ML, Abruzzo GK, Bartizal KF, Marrinan JA, Kurtz MB, McFadden DC, et al.

J Med Chem. 1994 Jan 21;37(2):222-5. No abstract available.

PMID:
8295208
49.

Serum immunoglobulin E and sudden cardiac arrest during myocardial infarction.

Szczeklik A, Dropiński J, Góra PF.

Coron Artery Dis. 1993 Nov;4(11):1029-32.

PMID:
8173709
50.

Persistent generation of thrombin after acute myocardial infarction.

Szczeklik A, Dropinski J, Radwan J, Krzanowski M.

Arterioscler Thromb. 1992 May;12(5):548-53.

Supplemental Content

Loading ...
Support Center